top of page
Untitled design - 2025-01-08T134450.286.png

Advanced Exosome Solutions

High-purity, research-backed exosome vials designed to enhance healing, recovery, and rejuvenation.

The Future of Regeneration

Discover The ExoGen Difference

At ExoGen Biotech Solutions, we are committed to providing regenerative medicine clinics with the most advanced solutions for improving patient outcomes. In collaboration with our premier biomanufacturing partner, Exoqure, we deliver cutting-edge Mesenchymal Stem Cell (MSC) products and exosomes derived from Wharton’s Jelly.

These products are designed to support clinicians in offering innovative therapies that enhance healing, reduce recovery times, and improve quality of life.

Untitled design - 2025-01-24T131301.240.png
Untitled design - 2025-01-08T134450.286.png

Our Vision:

Empowering Clinics, Transforming Lives

We are driven by the belief that regenerative medicine is the key to unlocking new possibilities for healing. By combining advanced science with decades of experience in patient care, ExoGen Biotech Solutions bridges the gap between innovation and real-world application, helping clinics thrive and patients recover faster.

Untitled design - 2025-01-24T135647.181.png

The Future of Regeneration

Our Product Offerings

Mesenchymal Stem Cells (MSCs)

Our MSCs are derived from Wharton’s Jelly, offering unmatched therapeutic potential. These stem cells are:

Immunoprivileged, reducing the risk of rejection.
Known for their ability to repair, regenerate, and modulate inflammation.
Ideal for a wide range of regenerative applications.

Exosomes

Exosomes are extracellular vesicles that play a critical role in cell communication and healing. Our Wharton’s Jelly-derived exosomes are:

Enriched with growth factors and bioactive molecules.
Engineered to support cell repair, anti-inflammation, and tissue regeneration.
A powerful addition to cutting-edge regenerative treatments.

Untitled design - 2025-01-08T134450.286.png

Reliability Meets Innovation

Why Choose Our Products?

With a focus on reliability and innovation, ExoGen Biotech Solutions ensures that every product meets the needs of clinicians striving to deliver superior patient care. By offering potent, ethically sourced MSCs and exosomes, we help regenerative medicine clinics expand their treatment capabilities and achieve outstanding results.

The Future of Regeneration

Uncompromising Quality at Every Stage

Our rigorous quality standards ensure the integrity and efficacy of every product we offer. Here’s how we achieve excellence:

1. GMP-Certified Manufacturing

All products are manufactured in ISO Class 5 cleanrooms under strict Good Manufacturing Practices (GMP).

Compliance with FDA 21 CFR 1271 and ISO 13485 ensures that our processes meet the most stringent regulatory requirements.

2. Stringent Testing Protocols

Donor Screening: We source Wharton’s Jelly exclusively from healthy, full-term births, ensuring ethical and traceable origins.

Product Testing: Each batch undergoes rigorous quality testing, including:
• Sterility
• Potency
• Purity
• Endotoxin levels

Testing occurs at multiple stages, from donor selection to cryopreservation, ensuring consistency and safety.

Untitled design - 2025-01-24T135647.181.png
Test Tubes

3. Advanced Cryopreservation

Products are stored using state-of-the-art cryopreservation methods to maintain their cellular integrity and therapeutic potential.

4. Ethical Sourcing and Transparency

We adhere to the highest ethical standards, sourcing MSCs and exosomes only from approved, ethical donations of Wharton’s Jelly.

Full traceability and documentation are available for every product, providing confidence to our clinical partners.

Untitled design - 2025-01-08T134450.286.png

Dedication to Excellence

Commitment to Clinicians and Patients

At ExoGen Biotech Solutions, we understand the trust clinicians place in the products they use. That’s why we go above and beyond to ensure every vial of MSCs or exosomes meets our rigorous quality benchmarks. Our dedication to excellence means better patient outcomes and greater confidence in regenerative therapies.

bottom of page